Table of Contents
Registration No. 333-_______
As filed with the Securities and Exchange
Commission on December 26, 2019
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________________
FORM S-3
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
__________________________
RADNET,
INC.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
|
13-3326724
|
(State or Other Jurisdiction of Incorporation or Organization)
|
(I.R.S. Employer Identification Number)
|
1510 Cotner Avenue
Los Angeles, California,
90025
(310) 478-7808
(Address, Including Zip Code, and Telephone Number, Including
Area Code, of Registrant’s
Principal Executive Offices)
__________________________
Howard G. Berger, M.D.
President and Chief Executive Officer
RadNet, Inc.
1510 Cotner Avenue
Los Angeles, California 90025
(310) 478-7808
(Name, Address, Including Zip Code, and
Telephone Number,
Including Area Code, of Agent for Service)
__________________________
Copies To:
Linda Giunta Michaelson, Esq.
|
James A. Mercer III, Esp.
|
Sheppard, Mullin, Richter & Hampton LLP
|
Sheppard Mullin Richter & Hampton LLP
|
1901 Avenue of the Stars, Suite 1600
|
12275 El Camino Real, Suite 200
|
Los Angeles, California 90067
|
San Diego, California 92130
|
(310) 228-3711
|
(858) 720-7469
|
__________________________
Approximate date of commencement
of proposed sale to the public:
From time to time after
this registration statement becomes effective.
If the only securities being registered
on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ¨
If any of the securities being registered
on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than
securities offered only in connection with dividend or interest reinvestment plans, check the following box. x
If this Form is filed to register additional
securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities
Act registration statement number of the earlier effective registration statement for the same offering. ¨
If this Form is filed to register additional
securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities
Act registration statement number of the earlier effective registration statement for the same offering. ¨
If this Form is a post-effective amendment
filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering. ¨
If this Form is a registration statement
pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission
pursuant to Rule 462(e) under the Securities Act, check the following box. x
If this Form is a post-effective amendment
to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes
of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ¨
Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth
company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting
company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer o
|
Accelerated filer ý
|
Non-accelerated filer o
|
Smaller reporting company o
|
|
Emerging growth company o
|
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 7(a)(2)(B). ¨
CALCULATION OF REGISTRATION FEE
Title of Each Class of Securities to be Registered
|
Amount to be Registered(1)
|
Proposed Maximum
Offering Price Per Unit/ Proposed Maximum
Aggregate Offering Price(1)
|
Amount of
Registration
Fee(2)
|
Primary Offering By Radnet, Inc.
|
|
|
|
Common Stock, par value $.0001 per share
|
|
-
|
-
|
Preferred Stock, par value $.0001 per share
|
|
-
|
-
|
Debt Securities
|
|
-
|
-
|
Warrants
|
|
-
|
-
|
Subscription Rights
|
|
-
|
-
|
Units (3)
|
|
-
|
-
|
Secondary Offering by Selling Stockholders
|
|
|
|
Common Stock, par value $.0001 per share
|
|
|
|
Total
|
|
-
|
-
|
|
(1)
|
An indeterminate
number and aggregate initial offering price of securities of each identified class are being registered as may from time to time
be offered at indeterminate prices, including an indeterminate number or amount of securities that may be issued upon the exercise,
settlement, exchange or conversion of securities offered hereunder. Separate consideration may or may not be received for securities
that are issuable upon conversion of, or in exchange for, or upon exercise of, convertible or exchangeable securities.
|
|
(2)
|
The registrant
is deferring payment of all of the registration fee and omitting information from the Calculation of Registration Fee table in
accordance with Rules 456(b) and 457(r) under the Securities Act.
|
|
(3)
|
Each unit will
represent an interest in two or more other securities registered hereunder, which may or may not be separable from one another.
|
PROSPECTUS
COMMON STOCK
PREFERRED STOCK
DEBT SECURITIES
WARRANTS
SUBSCRIPTION RIGHTS
UNITS
and
Common Stock
Offered by the Selling Stockholders
__________________________
From time to time, we may offer and sell
the securities described in this prospectus separately or together in any combination, in one or more classes or series, in amounts,
at prices and on terms that we will determine at the time of the offering. In addition, the selling stockholders identified in
this prospectus, or any of their transferees, donees, pledgees or other successors, may offer and sell from time to time shares
of common stock.
This prospectus provides you with a general
description of the securities we may offer. Each time we offer securities pursuant to this prospectus, we will provide a prospectus
supplement containing specific terms of the particular offering together with this prospectus. You should carefully read this prospectus,
the information incorporated by reference in this prospectus, the prospectus supplement, including any information incorporated
by reference in such prospectus supplement, and any free writing prospectus before you purchase any of the securities offered hereby.
The prospectus supplement also may add, update or change information contained in this prospectus. This prospectus may not be used
to offer and sell securities unless accompanied by the applicable prospectus supplement.
We may sell the securities directly to
investors, or to or through underwriters or dealers, and also to other purchasers or through agents. In addition, the underwriters,
if any, may over-allot a portion of the securities. The names of any underwriters, dealers or agents involved in the sale of our
securities, their compensation and any options held by them to purchase additional securities will be described in the applicable
prospectus supplement. See "Plan of Distribution."
The selling stockholders, or any of their
respective transferees, donees, pledgees or other successors, may offer and sell the common stock from time to time directly or
through underwriters, dealers or agents, or directly to purchasers, on a continued or delayed basis and at fixed prices, prevailing
market prices, at prices related to prevailing market prices or at negotiated prices. We will not receive any proceeds from the
sale of common stock by the selling stockholders.
Our common stock is listed on the NASDAQ
Global Market under the symbol “RDNT.” On December 23, 2019, the closing price of our common stock was $19.59 per share.
Investing in our securities involves
significant risks. We strongly recommend that you read carefully the risks we describe in this prospectus and in any accompanying
prospectus supplement, as well as the risk factors that are incorporated by reference into this prospectus from our filings made
with the Securities and Exchange Commission. See “Risk Factors” on page 5 of this prospectus.
Neither the Securities and Exchange
Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy
of this prospectus. Any representation to the contrary is a criminal offense.
The date of this prospectus is December
26, 2019
TABLE OF
CONTENTS
ABOUT THIS PROSPECTUS
This prospectus is part of an automatic
“shelf” registration statement on Form S-3 that we filed with the Securities and Exchange Commission (the “SEC”)
using an automatic shelf registration process. Under this shelf registration process, we may offer and sell from time to time any
combination of the securities described in this prospectus in one or more offerings in amounts, at prices and on terms that we
determine at the time of the offering.
In addition, the selling stockholders may
use this shelf registration statement to sell shares of our common stock from time to time. We will not receive any proceeds from
the sale of the shares by the selling stockholders. The selling stockholders may deliver a supplement with this prospectus, if
required, to update the information contained in this prospectus. The selling stockholders may sell their shares of common stock
through any means described in the section entitled “Plan of Distribution” or described in any accompanying prospectus
supplement. As used herein, the term “selling stockholders” includes the selling stockholders and any of their transferees,
donees, pledgees or other successors.
This prospectus only provides you with
a general description of the securities we may offer. Each time we offer securities under this prospectus we will provide a prospectus
supplement that describes the terms of the relevant offering. The prospectus supplement also may add, update or change information
contained in this prospectus. Before making an investment decision, you should read carefully both this prospectus and any prospectus
supplement and any free writing prospectus prepared by or on behalf of us, together with the documents incorporated by reference
into this prospectus as described below under the heading “Information Incorporated by Reference.”
This prospectus does not contain all of
the information included in the registration statement. For a more complete understanding of the offering of the securities, you
should refer to the registration statement, including its exhibits. Those exhibits may be filed with the registration statement
or may be incorporated by reference to earlier SEC filings listed in the registration statement or in subsequent filings that we
may make under the Securities Exchange Act of 1934 (the "Exchange Act").
We have not authorized anyone else to
provide you with information that is different or in addition to that contained or incorporated by reference in this prospectus
supplement, the accompanying prospectus or any free writing prospectus prepared by us or on our behalf. We do not take any responsibility
for, and can provide no assurance to the reliability of, any information that others may give. We are not making an offer to sell
or soliciting an offer to buy our securities under any circumstance in any jurisdiction where the offer or solicitation is not
permitted. You should assume that the information contained in this prospectus, any prospectus supplement or any free writing prospectus
prepared by us or on our behalf is accurate only as of the date of the respective document in which the information appears, and
that any information in documents that we have incorporated by reference is accurate only as of the date of the document incorporated
by reference, regardless of the time of delivery of this prospectus or any prospectus supplement or any sale of a security. Our
business, financial condition, results of operations and prospects may have changed since those dates.
This prospectus, any prospectus supplement
and the information incorporated herein and therein by reference includes trademarks, service marks and trade names owned by us
or other companies. All trademarks, service marks and trade names included or incorporated by reference into this prospectus supplement
or the accompanying prospectus are the property of their respective owners.
In this prospectus, unless otherwise indicated,
“our company,” “we,” “us,” “RadNet,” or “our” refer to RadNet, Inc.,
a Delaware corporation, and its consolidated subsidiaries.
ABOUT RADNET
Company Overview
We are the leading national provider of
freestanding, fixed-site outpatient diagnostic imaging services in the United States based on number of locations and annual imaging
revenue. At September 30, 2019, we operated directly or indirectly through joint ventures with hospitals, 340 centers located in
California, Delaware, Florida, Maryland, New Jersey, and New York. Our centers provide physicians with imaging capabilities to
facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, often reducing
the cost and amount of care for patients. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron
emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related
procedures. The vast majority of our centers offer multi-modality imaging services. Our multi-modality strategy diversifies revenue
streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs
of multiple procedures. Our operations compose a single segment for financial reporting purposes.
We seek to develop leading positions in
regional markets in order to leverage operational efficiencies. Our scale and density within selected geographies provides close,
long-term relationships with key payors, radiology groups and referring physicians. Each of our facility managers is responsible
for managing relationships with local physicians and payors, meeting our standards of patient service and maintaining profitability.
We provide corporate training programs, standardized policies and procedures and sharing of best practices among the physicians
in our regional networks.
In addition to our imaging services, one
of our subsidiaries, eRAD, Inc., develops and sells computerized systems for the imaging industry, including Picture Archiving
Communications Systems. Another one of our subsidiaries, Imaging On Call LLC, provides teleradiology services for remote interpretation
of images on behalf of radiology groups, hospitals and imaging center customers. In addition to providing alternative revenue sources
for us, the capabilities of both eRAD and Imaging On Call can make the RadNet imaging center operations more efficient and cost
effective.
Principal Executive Office
Our executive offices are located at 1510
Cotner Avenue, Los Angeles, California 90025 and our telephone number at that address is (310) 478-7808. Our corporate website
is www.radnet.com. Our filings with the SEC are posted on our website at www.radnet.com. Information contained on
our website or that can be accessed through our website is not incorporated by reference in this prospectus and does not constitute
a part of this prospectus.
WHERE YOU CAN FIND
MORE INFORMATION
We file annual, quarterly and current reports,
proxy statements and other information with the SEC. Our SEC filings are available to the public over the Internet at the SEC's
website at www.sec.gov. Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K,
including any amendments to those reports, and other information that we file with or furnish to the SEC pursuant to Section 13(a)
13(c), 14 or 15(d) of the Exchange Act can also be accessed free of charge on our website at www.radnet.com under "Investor
Relations”. These filings will be available as soon as reasonably practicable after we electronically file such material
with, or furnish it to, the SEC.
This prospectus is part of the registration
statement on Form S-3 that we filed with the SEC under the Securities Act as amended (the “Securities Act”)
and does not contain all the information set forth in the registration statement. The registration statement, including the attached
exhibits, contains additional relevant information about us and the securities. This prospectus does not contain all of the information
set forth in the registration statement. You can obtain a copy of the registration statement from the SEC's website at the address
listed above. The registration statement and the documents referred to below under "Incorporation by Reference" are also
available on our website, www.radnet.com. We have not incorporated by reference into this prospectus the information on,
or that can be accessed through, our website, and you should not consider it to be a part of this prospectus.
Whenever a reference is made in this prospectus
to any of our contracts, agreements or other documents, the reference may not be complete and you should refer to the exhibits
that are a part of the registration statement or the exhibits to the reports or other documents incorporated by reference into
this prospectus for a copy of such contract, agreement or other document. Note, however, that the
representations, warranties and covenants contained in those agreements were made only for purposes of those agreements and as
of specific dates, were solely for the benefit of the parties to those agreements, may be subject to limitations agreed upon by
the contracting parties, and may be subject to standards of materiality applicable to the contracting parties that differ from
those applicable to investors. Investors are not third-party beneficiaries under any of the agreements and should not rely on the
representations, warranties or covenants or any descriptions thereof as characterizations of the actual state of facts or condition
of the Company. Moreover, information concerning the subject matter of the representations and warranties may change after the
date of the agreements, which subsequent information may or may not be fully reflected in our public disclosures.
INFORMATION INCORPORATED
BY REFERENCE
The SEC allows us to “incorporate
by reference” information from other documents that we file with it, which means that we can disclose important information
to you by referring you to those documents. The information incorporated by reference is considered to be part of this prospectus.
Information in this prospectus supersedes information incorporated by reference that we filed with the SEC prior to the date of
this prospectus, while information that we file later with the SEC will automatically update and supersede the information in this
prospectus. We incorporate by reference into this prospectus and the registration statement of which this prospectus is a part
the information or documents listed below that we have filed with the SEC (Commission File No. 001-33307):
|
·
|
our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2019, June 30, 2019, and September
30, 2019, filed with the SEC on May 10, 2019, August 9, 2019, and November 12, 2019, respectively;
|
|
·
|
our Current Reports on Form 8-K filed with the SEC on February 25, 2019, March 15, 2019, April
19, 2019, May 10, 2019, June 14, 2019, August 8, 2019, August 9, 2019 and November 13, 2019 (but excluding the portions of such
reports expressly noted as being furnished and not filed);
|
|
·
|
the description of our common stock in our registration statement on Form 8-A, registering our
common stock under the Exchange Act, filed with the SEC on February 13, 2007 (as amended on February 14, 2007), pursuant to Section
12(b) of the Exchange Act, including any amendment or report filed for the purpose of updating such description.
|
All reports and other documents that we
subsequently file pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act prior to the completion of the sales of the
securities offered hereby but excluding any information furnished to, rather than filed with, the SEC (unless expressly incorporated
by reference herein), will also be incorporated by reference into this prospectus and deemed to be part of this prospectus from
the date of the filing of such reports and documents.
This prospectus, as supplemented, may contain
information that updates, modifies or is contrary to information in one or more of the documents incorporated by reference in this
prospectus. You should rely only on the information incorporated by reference or provided in this prospectus, the accompanying
prospectus supplement or any free writing prospectus that we have prepared that relates to a particular offering. We have not authorized
anyone else to provide you with different or additional information. You should not assume that the information in this prospectus
is accurate as of any date other than the date of this prospectus or the date of the documents incorporated by reference in this
prospectus.
We will furnish without charge to any beneficial
owner, on written or oral request, a copy of any or all of the documents incorporated by reference, including exhibits to these
documents. You should direct any requests for documents to: RadNet, Inc., 1510 Cotner Avenue Los Angeles, CA 90025, Attn: Legal
Department, or you may call us at (310) 478-7808.
RISK FACTORS
An investment in our company involves a
high degree of risk. The prospectus supplement applicable to each offering of our securities will contain a discussion of the risks
applicable to an investment in our securities. Before you make a decision to invest in our securities, you should consider carefully
the risks described in the section entitled “Risk Factors” contained in the applicable prospectus supplement and in
our most recent annual report on Form 10-K and quarterly reports on Form 10-Q filed with the SEC, as well as any amendment or update
thereto reflected in subsequent filings with the SEC or in any current report on Form 8-K we may file.
The risks and uncertainties described in
this prospectus, any applicable prospectus supplement and the documents incorporated by reference herein are not the only ones
that we face. Additional risks and uncertainties that we do not presently know about or that we currently believe are not material
may also adversely affect our business. Our business, results of operations or financial condition could be seriously harmed, and
the trading price of our securities may decline due to any of these or other risks and you might lose all or part of your investment.
CAUTIONARY NOTE REGARDING
FORWARD-LOOKING STATEMENTS
This prospectus, and prospectus supplement
and the documents incorporated herein and therein by reference contain forward-looking statements within the meaning of Section
27A of the Securities Act and Section 21E of the Exchange Act.
Forward-looking
statements reflect current views about future events and are based on our currently available financial, economic and competitive
data and on current business plans. Actual events or results may differ materially depending on risks and uncertainties that may
affect our operations, markets, services, prices and other factors.
In some cases, you can identify forward-looking
statements by terminology such as “may,” “will,” “should,” “expect,” “intend,”
“plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,”
“continue,” “assumption” or the negative of these terms or other comparable terminology. Statements concerning
our ability to successfully acquire and integrate new operations, to grow our contract management business, our financial guidance,
our future cost saving efforts, our ability to increase business from new equipment or operations and our ability to finance our
operations and repay our outstanding indebtedness, are forward-looking statements.
Forward-looking statements are not guarantees
of future performance and our actual results may differ significantly from the results discussed in the forward-looking statements.
Factors that might cause such differences include, but are not limited to, the factors included in “Risk Factors,”
in our annual report on Form 10-K for the fiscal year ended December 31, 2018 or supplemented by the information in Part II–
Item 1A below. You should consider the inherent limitations on, and risks associated with, forward-looking statements and not unduly
rely on the accuracy of predictions contained in such forward-looking statements.
These forward-looking statements speak
only as of the date when they are made. We assume no obligation to revise or update any forward-looking statements for any reason,
except as required by law.
USE OF PROCEEDS
Except as described in any applicable prospectus
supplement, we intend to use the net proceeds from the sale of the securities offered under this prospectus for general corporate
purposes, which may include working capital, capital expenditures, acquisitions and refinancing or repayment of indebtedness, including
the indebtedness under our senior secured credit facilities.
While we do not have any plans, arrangements
or commitments for any specific acquisitions or investments at this time, we believe opportunities may exist from time to time
to expand our current business through strategic alliances or acquisitions.
When specific securities are offered, the
prospectus supplement relating thereto will set forth our intended use of the net proceeds that we receive from the sale of such
securities. Pending the application of the net proceeds, we may invest the proceeds in marketable securities and short-term investments.
We will not receive any
proceeds from the sale of common stock by the selling stockholders pursuant to this prospectus. We have agreed to pay all costs,
expenses and fees relating to registering the shares of our common stock to be sold by the selling stockholders and referenced
in this prospectus. The selling stockholders will pay any brokerage commissions and/or similar charges incurred for the sale of
such shares of our common stock.
DESCRIPTION OF COMMON
STOCK
We may issue, separately or together with,
or upon conversion, exercise or exchange of other securities, common stock, as set forth in the applicable prospectus supplement.
The following description of our common stock, together with the additional information we include in any prospectus supplement,
summarizes the material terms and provisions of the common stock that we may offer pursuant to this prospectus. For the complete
terms of our common stock, please refer to our current certificate of incorporation, as amended to date, or our bylaws, which have
been filed with the SEC and are incorporated herein by reference. The terms of these securities may also be affected by the Delaware
General Corporation Law. The summary below and any update which may be contained in any prospectus supplement is qualified in its
entirety by reference to our certificate of incorporation, as amended to date, and our bylaws, as either may be amended from time
to time after the date of this prospectus, but before the date of any such prospectus supplement.
Authorized Capitalization
We are authorized to issue 200,000,000
shares of common stock having a par value of $.0001 per share and 30,000,000 shares of preferred stock having a par value of $.0001
per share. As of November 6, 2019, we had 50,311,829 shares of common stock outstanding and no shares of preferred stock outstanding.
Our authorized shares of common stock are
available for issuance without further action by our stockholders, unless such action is required by applicable law or the rules
of any stock exchange or automated quotation system on which our securities may be listed or traded. If the approval of our stockholders
is not so required, our board of directors may determine not to seek stockholder approval.
Dividends
Subject to the preferences that may apply
to shares of preferred stock outstanding at the time, the holders of outstanding shares of our common stock are entitled to receive
dividends out of assets legally available at the times and in the amounts that our board of directors may from time to time declare.
Voting Rights
Each holder of our common stock is entitled
to one vote per share on all matters submitted to a vote of stockholders, and may not cumulate votes for the election of directors.
Our certificate of incorporation does not provide for any preemptive rights.
Preemptive Rights; Redemption or Sinking Fund
Holders of common stock have no preemptive,
conversion or subscription rights. There are no redemption or sinking fund provisions applicable to our common stock.
Liquidation Rights
If we liquidate, dissolve or wind up, holders
of our common stock are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preferences
of any outstanding shares of preferred stock.
Listing; Transfer Agent and Registrar
Our common stock is listed on The Nasdaq
Global Market under the symbol "RDNT." The transfer agent and registrar for our common stock is American Stock Transfer
and Trust Company. Their address is 6201 15th Avenue, Brooklyn, NY 11219 and their telephone number is (800) 937-5449.
Warrants
As of September 30, 2019, we had no outstanding
warrants to purchase our common stock.
Anti-Takeover Effects of Provisions of Delaware Law and
Our Charter Documents
The following provisions of Delaware law
and our certificate of incorporation and bylaws may affect the control of our company.
Delaware General Corporation Law
Section 203 of the Delaware General Corporation
Law (“DGCL”), generally prohibits any Delaware corporation from engaging in any “business combination”
with any “interested stockholder” for a period of three years following the date the stockholder became an interested
stockholder, unless:
|
·
|
prior to that date the board of directors approved either the business combination or the transaction
that resulted in the stockholder becoming an interested stockholder;
|
|
·
|
upon completion of the transaction that resulted in the stockholder becoming an interested stockholder,
the interested stockholder owned at least 85% of the voting stock outstanding at the time the transaction commenced, excluding
(for purposes of calculating the total voting stock outstanding) shares held by inside directors or employee stock plans which
do not grant the right to tender shares confidentially; or
|
|
·
|
on or following that date, the business combination is approved by the board of directors and authorized
at an annual or special meeting of stockholders by the affirmative vote of at least two-thirds of the outstanding voting stock
that is not owned by the interested stockholder.
|
Section 203 generally defines a “business
combination” to include:
|
·
|
any merger or consolidation of the corporation or any of its direct or indirect majority-owned
subsidiaries with either the interested stockholder or any other person or entity if the transaction is caused by the interested
stockholder;
|
|
·
|
any sale, lease, transfer, pledge or other disposition of the assets of the corporation or any
direct or indirect majority-owned subsidiary involving the interested stockholder if the value of the assets exceeds 10% or more
of the market value of the corporation’s consolidated assets or outstanding stock;
|
|
·
|
subject to specified exceptions, any transaction that results in the issuance or transfer by the
corporation or any of its direct or indirect majority-owned subsidiaries of any stock of the corporation or the subsidiary to the
interested stockholder;
|
|
·
|
any transaction involving the corporation or any of its direct or indirect majority-owned subsidiaries
that has the effect of increasing the proportionate share of the stock of any class or series of the corporation or the subsidiary
beneficially owned by the interested stockholder; or
|
|
·
|
the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges
or other financial benefits provided by or through the corporation or any of its direct or indirect majority-owned subsidiaries.
|
In general, Section 203 defines an “interested
stockholder” as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation
and any entity or person affiliated with or controlling or controlled by that entity or person.
Section 203 of the Delaware General Corporation
Law could depress our stock price and delay, discourage or prohibit transactions not approved in advance by our board of directors,
such as takeover attempts that might otherwise involve the payment to our stockholders of a premium over the market price of our
common stock.
Certificate of Incorporation and Bylaw Provisions.
Some provisions of our certificate of incorporation
and bylaws may have an anti-takeover effect and may delay, defer or prevent a tender offer or takeover attempt that a stockholder
might deem to be in its, his or her best interest. The existence of these provisions might reduce the price that investors would
be willing to pay in the future for shares of our common stock or other securities. These provisions include:
|
·
|
Special stockholder meetings. Only a majority of the members of our board of directors,
or a duly authorized committee thereof, may call a special meeting of stockholders, provided, however, that if and to the extent
that any special meeting of stockholders may be called by any other person or persons specified in any certificate of designations
filed under Section 151(g) of the DGCL (or its successor statute as in effect from time to time), then such special meeting may
also be called by the person or persons, in the manner, at the times and for the purposes so specified.
|
|
·
|
Advance Notification of Shareholder Nominations and Proposals. Our bylaws establish advance
notice procedures with respect to shareholder proposals and the nomination of candidates for election as directors, other than
nominations made by or at the direction of the board of directors or a committee of the board of directors. The bylaws do not give
the board of directors the power to approve or disapprove shareholder nominations of candidates or proposals regarding business
to be conducted at a special or annual meeting of the shareholders. However, our bylaws may have the effect of precluding the conduct
of certain business at a meeting if the proper procedures are not followed. These provisions may also discourage or deter a potential
acquiror from conducting a solicitation of proxies to elect the acquiror's own slate of directors or otherwise attempting to obtain
control of us.
|
|
·
|
Authorized but unissued shares. Our board of directors may designate and issue authorized
but unissued shares of preferred stock (as well as issue shares of authorized but unissued common stock) without stockholder approval,
subject to certain limitations imposed by the NASDAQ Stock Market. These additional shares may be utilized in an effort to dilute
the stock ownership and voting power of persons seeking to obtain control of our company, including by implementation of a stockholder
rights plan, or may be issued to investors who would support our board of directors in opposing an unsolicited takeover bid.
|
|
·
|
Number of directors. Our board of directors has the authority to increase the number of
directors as stated in our bylaws, and may fill the vacancies created by such action without stockholder approval.
|
|
·
|
No Cumulative Voting. Our certificate of incorporation does not permit stockholders to cumulate
votes in the election of directors.
|
|
·
|
Transfer restrictions. Our certificate of incorporation contains provisions generally restricting
any direct or indirect transfer of shares of our capital stock where the transferee(s), individually or collectively, is or would
become a “5-percent shareholder,” as such term is defined in the U.S. Internal Revenue Service Treasury Regulation
ss. 1.382-2T(g) (referred to herein as the Treasury Regulation), or would increase the ownership percentage of an existing 5-percent
shareholder. Such transfer restrictions are intended to preserve certain of our tax assets and any attempted transfer of our capital
stock to a 5-percent shareholder in violation of the provisions of our certificate of incorporation will be void ab initio. Under
the Treasury Regulation, 5-percent shareholder generally means an individual or group that owns five percent or more of the applicable
company, however, the Treasury Regulation is complex and you are encouraged to consult with your tax advisors to determine whether
or not you are a 5-percent shareholder for purposes of the Treasury Regulation.
|
Indemnification Provisions
Delaware General Corporation Law
Section 145 of the DGCL permits a corporation
to indemnify any director, officer, employee or agent of the corporation, or other person who is or was serving at the request
of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other
enterprise, any such person we refer to as an indemnitee, against expenses (including attorney’s fees), judgments, fines
and amounts paid in settlement actually and reasonably incurred in connection with any action, suit or proceeding brought by reason
of the fact that the indemnitee is or was serving the corporation or another entity at the direction of the corporation, provided
that the indemnitee acted in good faith and in a manner that he or she reasonably believed to be in, or not opposed to, the best
interests of the corporation, and, with respect to any criminal action or proceeding, if he or she had no reason to believe his
or her conduct was unlawful. In a derivative action (i.e., one brought by or on behalf of the corporation), indemnification may
be provided only for expenses actually and reasonably incurred by the indemnitee in connection with the defense or settlement of
such an action or suit if the indemnitee acted in good faith and in a manner that he or she reasonably believed to be in, or not
opposed to, the best interests of the corporation, except that no indemnification shall be provided if the indemnitee is adjudged
to be liable to the corporation, unless and only to the extent that the court in which the action or suit was brought determines
that the indemnitee is fairly and reasonably entitled to indemnity for his or her expenses despite the adjudication of liability.
Section 145(g) of the DGCL also provides
that a corporation may maintain insurance against liabilities even if the corporation would lack the power under the DGCL to indemnify
against those liabilities.
Certificate of Incorporation and Bylaws
Article Ninth of our certificate of incorporation
provides that a director is not liable to us or our stockholders for monetary damages for breach of fiduciary duty as a director
to the fullest extent permitted by the DGCL. It further obligates us, with respect to our officers and directors, and permits us,
with respect to our employees and agents, to indemnify, in the manner and to the fullest extent permitted by the DGCL, any person
(or the estate of any person) who is or was a party to, or is threatened to be made a party to, any threatened, pending or completed
action, suit or proceeding, whether or not by or in the right of RadNet, and whether civil, criminal, administrative, investigative
or otherwise, by reason of the fact that the person is or was a director or officer, or employee or agent, as the case may be,
of RadNet, or is or was serving at the request of RadNet as a director or officer, or employee or agent, as the case may be, of
another corporation or entity.
We may advance the expenses incurred by
any such director, officer, employee or agent in defending any such action, suit or proceeding prior to its final disposition upon
receipt of an undertaking by the recipient to repay the amounts advanced if it is ultimately determined that he or she is not entitled
to be indemnified as authorized by the DGCL and our certificate of incorporation. To the fullest extent permitted by the DGCL,
the indemnification provided in the certificate of incorporation includes expenses (including attorneys’ fees), judgments,
fines and amounts paid in settlement and, in the manner provided by the DGCL, we may pay any of these expenses in advance of the
final disposition of such action, suit or proceeding.
Article VII of our bylaws contains provisions
substantially similar to Article Ninth of our certificate of incorporation. In addition, our bylaws obligate us to indemnify each
of our officers, directors, employees and agents in any action, suit or proceeding referred to above to the extent that person
has been successful on the merits in defense thereof, or in defense of any claim, issue or matter therein, against expenses (including
attorneys’ fees) actually and reasonably incurred by that person in connection therewith. Our bylaws obligate us to advance
expenses to our officers and directors, and require an undertaking to repay expenses under the specified conditions if required
by applicable law.
General
We have also entered into separate indemnification
agreements with our officers and directors, pursuant to which we have agreed indemnify the officer or director against all liabilities
relating to his or her position as an officer or director of RadNet, or as an employee, agent, officer or director of any other
entity if the officer or director is serving in that capacity at our request, to the fullest extent permitted under applicable
law.
We also maintain insurance for our officers
and directors against certain liabilities, including liabilities under the Securities Act. The effect of this insurance is to indemnify
any of our officers or directors against expenses, including attorneys’ fees, judgments, fines and amounts paid in settlement,
incurred by an officer or director upon a determination that such person acted in good faith. RadNet pays the premiums for this
insurance.
Insofar as indemnification for liabilities
arising under the Securities Act may be permitted to our directors, officers or controlling persons pursuant to the foregoing provisions,
we have been informed that, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities
Act and is, therefore, unenforceable. In addition, indemnification for violations of state securities laws may be limited by applicable
laws.
DESCRIPTION OF PREFERRED
STOCK
We may issue, separately or together with,
or upon conversion, exercise or exchange of other securities, preferred stock, par value $0.0001 per share, as set forth in the
applicable prospectus supplement. Subject to the limitations imposed by law and the rules of the NASDAQ Stock Market, our board
of directors is authorized to designate and issue up to 30,000,000 shares of preferred stock in one or more series, without further
stockholder approval.
Our board of directors is authorized from
time to time to fix the designations and the powers, preferences and relative, participating, optional or other special rights,
and qualifications, limitations or restrictions thereof, including, without limitation, the dividend rate, conversion or exchange
rights, redemption price and liquidation preference, of any series of shares of preferred stock, and to fix the number of shares
constituting any such series, and to increase or decrease the number of shares of any such series (but not below the number of
shares thereof then outstanding). Any or all of these rights may be superior to the rights of the common stock.
A prospectus supplement relating to a series
of preferred stock will describe terms of that series of preferred stock, including:
|
·
|
the designation and stated value of that series;
|
|
·
|
the number of shares of preferred stock we are offering;
|
|
·
|
the initial public offering price at which the shares of preferred stock will be sold;
|
|
·
|
the dividend rate of that series, the conditions and dates upon which those dividends will be payable,
whether those dividends will be cumulative or noncumulative, and, if cumulative, the date from which dividends will accumulate;
|
|
·
|
the process for any auction and remarketing, if any;
|
|
·
|
the relative ranking and preferences of that series as to dividend rights and rights upon any liquidation,
dissolution or winding up of the affairs of our company;
|
|
·
|
any redemption, repurchase, or sinking fund provisions;
|
|
·
|
any conversion or exchange rights of the holder or us;
|
|
·
|
any restrictions on transfer, sale or other assignment;
|
|
·
|
any restrictions on further issuances;
|
|
·
|
whether interests in the preferred stock will be represented by depositary shares;
|
|
·
|
a discussion of any material United States federal income tax considerations applicable to the
preferred stock;
|
|
·
|
any application for listing of that series on any securities exchange or market;
|
|
·
|
any limitations on the issuance of any class or series of preferred stock ranking senior to or
on a parity with the series of preferred stock as to dividend rights and rights upon liquidation, dissolution or winding up of
our company’s affairs; and
|
|
·
|
any other specific terms, preferences, rights or limitations of, or restrictions on, that series
of preferred stock.
|
The issuance of preferred stock will affect,
and may adversely affect, the rights of holders of common stock.
It is not possible to state the actual
effect of the issuance of any shares of preferred stock on the rights of holders of common stock until our board of directors determines
the specific rights, preferences and privileges attached to that series of preferred stock. The effects of issuing preferred stock
could include one or more of the following:
|
·
|
restricting dividends on the common stock;
|
|
·
|
diluting the voting power of the common stock;
|
|
·
|
impairing the liquidation rights of the common stock; or
|
|
·
|
delaying or preventing changes in control or management.
|
As of
the date of this prospectus, no shares of preferred stock were outstanding and our board of directors has made no provision for
this issuance of any series of preferred stock.
DESCRIPTION OF DEBT
SECURITIES
We may issue senior debt securities or
subordinated debt securities (any of which may be convertible or not convertible). We use the term debt securities in this prospectus
to refer to both senior debt securities and subordinated debt securities. No debt securities will be secured by any of our property
or assets or the property or assets of any of our subsidiaries. No debt securities will be guaranteed by any of our subsidiaries
or any other person or entity. Thus, by owning a debt security, you will be an unsecured creditor of RadNet.
The senior debt securities will be issued
under our senior debt indenture described below and will rank equally with all of our other unsecured and unsubordinated debt.
The subordinated debt securities will be issued under our subordinated debt indenture described below and will be subordinate in
right of payment to all of our “senior debt,” as defined in the subordinated debt indenture. We use the term indentures
in this prospectus to refer to both the senior debt indenture and the subordinated debt indenture. Neither indenture limits our
ability to incur additional unsecured indebtedness, unless otherwise described in the prospectus supplement relating to any series
of debt securities.
The following summary does not purport
to be complete and is subject to, and is qualified in its entirety by reference to, all provisions of the indentures, including
definitions of various terms contained in the indentures. Copies of the entire indentures are exhibits to the registration statement
of which this prospectus is a part, and are incorporated herein by reference. We encourage you to read the full text of the indentures,
which you can obtain as described under the heading “Where You Can Find More Information” elsewhere in this prospectus.
While the terms we have summarized below will apply generally to any future debt securities we may offer under this prospectus,
the applicable prospectus supplement or free writing prospectus will describe the specific terms of any debt securities offered
through that prospectus supplement or free writing prospectus. The terms of any debt securities we offer under a prospectus supplement
or free writing prospectus may differ from the terms we describe below.
RadNet is a holding company and a legal
entity separate and distinct from its subsidiaries, through which RadNet conducts its operations and which generate all of RadNet’s
operating income and cash flow. As a result, RadNet’s only source of funds to meet its obligations to make payments under
any debt securities as well as its other payment obligations is distributions or advances from RadNet’s subsidiaries. Contractual
provisions, laws or regulations may limit the ability of RadNet to obtain the necessary funds from its subsidiaries to satisfy
its obligations. RadNet’s rights to participate in the distribution of assets of its subsidiaries are effectively subordinate
to the claims of creditors, including trade creditors, of those subsidiaries, except to the extent that RadNet itself may be a
creditor of a particular subsidiary with recognized claims. Accordingly, except to the extent that RadNet itself may be a creditor
of a subsidiary with recognized claims, RadNet’s obligations under its debt securities will be effectively subordinated to
all existing and future indebtedness and liabilities of its subsidiaries.
The Indentures
The senior debt securities and the subordinated
debt securities are each governed by an agreement called an indenture – the senior debt indenture, in the case of the senior
debt securities, and the subordinated debt indenture, in the case of the subordinated debt securities. Each indenture is a contract
between us and the trustee under the indenture. The indentures are substantially identical, except for the provisions relating
to subordination, which are included only in the subordinated debt indenture.
At or prior to the time of offering of
any series of debt securities, we will appoint a trustee under the applicable indenture. We will identify the trustee in the prospectus
supplement offering any series of debt securities.
The trustee under each indenture has two
principal roles:
|
·
|
The trustee can enforce the rights of the holders against us if we default on our obligations under
the terms of the indenture or the debt securities. There are some limitations on the extent to which the trustee acts on behalf
of the holders, described below under the heading – “Events of Default.”
|
|
·
|
The trustee performs administrative duties for us, such as sending interest payments and notices
to holders, and transferring a holder’s debt securities to a new buyer if a holder sells.
|
Reference to the indenture or the trustee
with respect to any debt securities, means the indenture under which those debt securities are issued and the trustee under that
indenture.
Conversion or Exchange Rights
We will set forth in the applicable prospectus
supplement or free writing prospectus the terms on which a series of debt securities may be convertible into or exchangeable for
our common stock, our preferred stock or other securities (including securities of a third-party). We will include provisions as
to whether conversion or exchange is mandatory, at the option of the holder or at our option. We may include provisions pursuant
to which the number of shares of our common stock, our preferred stock or other securities (including securities of a third-party)
that the holders of the series of debt securities receive would be subject to adjustment.
Terms
We may issue as many distinct series of
debt securities under either debt indenture as we wish. The provisions of each indenture allow us not only to issue debt securities
with terms different from those previously issued under that indenture, but also to “reopen” a previous issue of a
series of debt securities and issue additional debt securities of that series. We may issue debt securities in amounts that exceed
the total amount specified on the cover of a prospectus supplement at any time without notification or consent.
This section summarizes the material terms
of the debt securities that are common to all series, although the prospectus supplement which describes the terms of each series
of debt securities may also describe differences from the material terms summarized here. This summary is subject to and qualified
by reference to the description of the particular terms of any series described in the applicable prospectus supplement. Those
terms may vary from the terms described in this prospectus. There may also be a further prospectus supplement, known as a pricing
supplement or free writing prospectus, which contains the precise terms of debt securities you may be offered.
In this summary, we describe the meaning
of only some of the more important terms. Whenever we refer to particular sections or defined terms of the indenture in this prospectus
or in the prospectus supplement, such sections or defined terms are incorporated by reference here or in the prospectus supplement.
You must look to the indenture for the most complete description of what we describe in summary form in this prospectus.
We may issue the debt securities as original
issue discount securities, which will be offered and sold at a substantial discount below their stated principal amount. The prospectus
supplement relating to the original issue discount securities will describe federal income tax consequences and other special considerations
applicable to them. The debt securities may also be issued as indexed securities or securities denominated in foreign currencies
or currency units, as described in more detail in the prospectus supplement relating to any of the particular debt securities.
The prospectus supplement relating to a
series of debt securities will describe the terms of the series including:
|
·
|
the title of the series of debt securities;
|
|
·
|
whether they are senior debt securities or subordinated debt securities;
|
|
·
|
any limit on the aggregate principal amount of the series of debt securities;
|
|
·
|
the person to whom interest on a debt security is payable, if other than the holder on the regular
date;
|
|
·
|
the specified currency, currencies or currency, units for principal and interest, if not U.S. dollars;
|
|
·
|
the rate or rates, which may be fixed or variable per annum, at which the series of debt securities
will bear interest, if any, and the date or dates from which that interest, if any, will accrue;
|
|
·
|
the place or places where the principal of, premium, if any, and interest on the debt securities
will be payable;
|
|
·
|
the denominations in which the debt securities will be issuable, if other than denominations of
$1,000 and any integral multiple of $1,000;
|
|
·
|
any mandatory or optional sinking funds or similar provisions or provisions for redemption at the
option of the issuer;
|
|
·
|
the date, if any, after which and the price or prices at which the series of debt securities may,
in accordance with any option or mandatory redemption provisions, be redeemed and the other detailed terms and provisions of those
optional or mandatory redemption provisions, if any;
|
|
·
|
any index or formula used to determine the amount of payments of principal of and any premium and
interest on the debt securities;
|
|
·
|
if the debt securities may be converted into or exchanged for our common stock, preferred stock
or other securities, the terms on which conversion or exchange may occur, including whether conversion or exchange is mandatory,
at the option of the holder or at our option, the period during which conversion or exchange may occur, the initial conversion
or exchange rate and the circumstance or manner in which the amount of common or preferred stock issuable upon conversion or exchange
may be adjusted or calculated according to the market price of our common stock or preferred stock or such other securities;
|
|
·
|
if the debt securities are original issue discount debt securities, the yield to maturity;
|
|
·
|
the applicability of any provisions described under the heading – “Defeasance and Covenant
Defeasance” below;
|
|
·
|
any event of default under the series of debt securities if different from those described under
the heading “– Event of Default” below;
|
|
·
|
the names and duties of any co-trustees, authenticating agents, paying agents, transfer agents
or registrars for the debt securities;
|
|
·
|
if the series of debt securities will be issuable only in the form of a global security, the depositary
or its nominee with respect to the series of debt securities and the circumstances under which the global security may be registered
for transfer or exchange in the name of a person other than depository or the nominee;
|
|
·
|
if the debt securities are guaranteed, the identity of the subsidiary guarantors providing the
guarantees and a description of the terms of the guarantees; and
|
|
·
|
any other terms of the debt securities, which could be different from or in addition to those described
in this prospectus.
|
Form, Exchange and Transfer
Unless we indicate otherwise in the prospectus
supplement, the debt securities will be issued:
|
·
|
only in fully registered form; and
|
|
·
|
in denominations of $1,000 and integral multiples of $1,000.
|
Holders may exchange their debt securities
for debt securities of the same series in any authorized denominations, as long as the total principal amount is not changed.
Holders may exchange or transfer their
debt securities at the office of the trustee. They may also replace lost, stolen or mutilated debt securities at that office. The
trustee acts as our agent for registering debt securities in the names of the holders and transferring debt securities.
Holders will not be required to pay a service
charge to transfer or exchange their debt securities, but they may be required to pay for any tax or other governmental charge
associated with the registration, exchange or transfer. The transfer or exchange, and any replacement, will be made only if our
transfer agent is satisfied with the holder’s proof of legal ownership. The transfer agent may require an indemnity before
replacing any debt securities.
If a debt security is issued as a global
debt security, only the depositary will be entitled to transfer and exchange the debt security as described in this subsection,
since the depositary will be the sole holder of the debt security.
If a debt security is issued as a registered
global debt security, only the depositary – such as DTC, Euroclear and Clearstream, each as defined in the section “Legal
Ownership of Securities” below – will be entitled to transfer and exchange the debt security as described in this subsection,
since the depositary will be the sole holder of the debt security. Those who own beneficial interests in a global security do so
through participants in the depositary’s securities clearance system, and the rights of these indirect owners will be governed
solely by the applicable procedures of the depositary and its participants. We describe book-entry procedures in the section “Legal
Ownership of Securities” below.
We will not deposit money on a regular
basis into any separate custodial account to repay the debt securities. In addition, we will not be entitled to redeem a debt security
before its stated maturity unless the prospectus supplement specifies a redemption commencement date. You will not be entitled
to require us to buy a debt security from you before its stated maturity unless your prospectus supplement specifies one or more
repayment dates.
If the debt securities are redeemable and
we redeem less than all of the debt securities of a particular series, we may block the transfer or exchange of debt securities
during the period beginning 15 days before the day we mail the notice of redemption and ending on the day of that mailing, in order
to freeze the list of holders to prepare the mailing. We may also refuse to register transfers or exchanges of debt securities
selected for redemption, except that we will continue to permit transfers and exchanges of the unredeemed portion of any debt security
being partially redeemed.
The rules for exchange described above
apply to an exchange of debt securities for other debt securities of the same series and kind. If a debt security is convertible,
or exchangeable into or for a different kind of security, the terms governing that type of conversion or exchange will be described
in the prospectus supplement.
Payment and Paying Agents
If interest is due on a debt security on
an interest payment date, we will pay the interest to the person in whose name the debt security is registered at the close of
business on the regular record date relating to the interest payment date as will be specified in the applicable prospectus supplement.
If interest is due at maturity but on a day that is not an interest payment date, we will pay the interest to the person entitled
to receive the principal of the debt security. If principal or another amount besides interest is due on a debt security at the
stated maturity, we will pay the amount to the holder of the debt security against surrender of the debt security at a proper place
of payment or, in the case of a global debt security, in accordance with the applicable policies of the depositary.
We will make payments on a global security
in accordance with the applicable policies of the depositary as in effect from time to time. Under those policies, we will make
payments directly to the depositary, or its nominee, and not to any indirect owners who own beneficial interests in the global
security.
Book-entry and other indirect holders should
consult their banks, brokers or other financial institutions for information on how they will receive payments.
We will make payments on a debt security
in non-global, registered form as follows. We will pay interest that is due on an interest payment date by check mailed on the
interest payment date to the holder at his or her address shown on the trustee’s records as of the close of business on the
regular record date. We will make all other payments by check to the paying agent against surrender of the debt security.
All payments will be made in U.S. Dollars
unless the prospectus supplement provides otherwise. If payments are to be made in currency other than U.S. Dollars, such payments
for debt security in non-global, registered form will be made by wire transfer of immediately available funds to any account that
is maintained in the applicable specified currency at a bank designated by the holder and which is acceptable to us and the trustee.
To designate an account for wire payment, the holder must give the paying agent appropriate wire instructions at least five business
days before the requested wire payment is due. If we are obligated to make a payment in a specified currency other than U.S. Dollars,
and the specified currency or any successor currency is not available to us due to circumstances beyond our control we will be
entitled to satisfy our obligation to make the payment by making the payment in U.S. Dollars, on the basis of the exchange rate
determined by the designated exchange agent, in its discretion.
We may appoint one or more financial institutions
to act as our paying agents, at whose designated offices debt securities in non-global entry form may be surrendered for payment
at their maturity. We call each of those offices a paying agent. We may add, replace or terminate paying agents from time to time.
We may also choose to act as our own paying agent. Initially, the appointed trustee will act as the paying agent.
Regardless of who acts as paying agent,
all money paid by us to a paying agent that remains unclaimed at the end of two years after the amount is due to a holder will
be repaid to us. After that two-year period, the holder may look only to us for payment and not to the trustee, any other paying
agent or anyone else.
Notices
Notices to be given to holders of a global
debt security will be given only to the depositary, in accordance with its applicable policies as in effect from time to time.
Notices to be given to holders of debt securities not in global form will be sent by mail to the respective addresses of the holders
as they appear in the trustee’s records. Neither the failure to give any notice to a particular holder, nor any defect in
a notice given to a particular holder, will affect the sufficiency of any notice given to another holder.
Mergers and Similar Transactions
Under the terms of the applicable indenture,
we will generally be permitted to merge or consolidate with another entity. We will also generally be permitted to sell our assets
substantially as an entirety to another entity. With regard to any series of debt securities, however, unless otherwise indicated
in the applicable prospectus supplement, we may not take any of these actions unless all of the following conditions are met:
|
·
|
If we are not the successor entity in the transaction, the successor entity must be a corporation,
partnership, limited liability company or trust organized under the laws of the United States, any state in the United States or
the District of Columbia and must expressly assume our obligations under the debt securities of that series and the indenture with
respect to that series.
|
|
·
|
Immediately after giving effect to the transaction, no default under the debt securities of that
series has occurred and is continuing. For this purpose, “default under the debt securities of that series” means an
event of default with respect to that series or any event that would be an event of default with respect to that series if the
requirements for giving us a default notice and for our default having to continue for a specific period of time were disregarded.
|
|
·
|
We have delivered to the trustee an officers’ certificate and opinion of counsel, each stating
that the transaction complies in all respects with the indenture.
|
If the conditions described above are satisfied
with respect to the debt securities of any series, we will not need to obtain the approval of the holders of those debt securities
in order to merge or consolidate or to sell our assets. Also, these conditions will apply only if we wish to merger or consolidate
with another entity or sell our assets substantially as an entirety to another entity. We will not need to satisfy these conditions
if we enter into other types of transactions, including any transaction in which we acquire stock or assets of another entity,
any transaction that involves a change of control of us but in which we do not merge or consolidate and any transaction in which
we sell less than substantially all of our assets.
Defeasance and Covenant Defeasance
Any series of issued debt securities may
be subject to the defeasance and discharge provisions of the applicable indenture. Under those provisions, the debt securities
of any series may authorize us to elect to:
|
·
|
defease and to discharge us from any and all obligations with respect to those debt securities,
except for the rights of holders of those debt securities to receive payments on the securities solely from the trust fund established
pursuant to the applicable indenture and the obligations to exchange or register the transfer of the securities, to replace temporary
or mutilated, destroyed, lost or stolen securities, to maintain an office or agency with respect to the securities and to hold
moneys for payment in trust, which we refer to as a defeasance; or
|
|
·
|
to be released from our obligations with respect to those debt securities to comply with the restrictive
covenants which are subject to covenant defeasance, and the occurrence of certain events of default with respect to those restrictive
covenants shall no longer be an event default, which we refer to as a covenant defeasance.
|
To invoke defeasance or covenant defeasance
with respect to any series of debt securities, we must irrevocably deposit with a trustee, in trust, money or U.S. Government obligations,
or both, which will provide money in an amount sufficient to pay all sums due on that series.
As a condition to defeasance or covenant
defeasance, we must deliver to the applicable indenture trustee an officers certificate and an opinion of counsel stating that
holders of the applicable debt securities will not recognize gain or loss for federal income tax purposes as a result of the defeasance
or covenant defeasance and will be subject to federal income tax on the same amounts, in the same manner and at the same times
as would have been the case if we did not elect the defeasance or covenant defeasance. We may exercise our defeasance option with
respect to the securities notwithstanding our prior exercise of our covenant defeasance option. If we exercise our defeasance option,
payment of the securities may not be accelerated by the reference to restrictive covenants which are subject to covenant defeasance.
If we do not comply with our remaining obligations after exercising our covenant defeasance option and the debt securities are
declared due and payable because of the occurrence of any event of default, the amount of money and U.S. Government obligations
on deposit in the defeasance trust may be insufficient to pay amounts due on the securities at the time of the acceleration. However,
we will remain liable for those payments.
Modification and Waiver of the Debt Securities
We may change or modify either of the indentures
without the consent of the holders of the debt securities so long as such changes are limited to clarifications and/or changes
that would not adversely affect the debt securities of that series in any material respect. We may also make changes that may affect
the debt securities that have yet to be issued under the applicable indentures without the approval of any holders.
If the proposed change shall affect the
debt securities of a particular series then we must obtain approval of the holders of a majority in principal amount of the debt
securities of that series. If the proposed change will affect the debt securities of more than one series of debt securities issued
under the applicable indenture then we must obtain approval of the holders of a majority in principal amount of each series affected
by the change.
We may not amend the subordinated debt
indenture to alter the subordination of any outstanding subordinated debt securities without the written consent of each holder
of senior debt then outstanding who would be adversely affected. In addition, we may not modify the subordination provisions of
the subordinated debt indenture in a manner that would adversely affect the outstanding subordinated debt securities of any one
or more series in any material respect, without the approval of the holders of a majority in aggregate principal amount of all
affected series, voting together as one class.
In each case, the required approval must
be given by written consent.
Book-entry and other indirect holders should
consult their banks, brokers or other financial institutions for information on how approval may be granted or denied if we seek
to change or modify either indenture or the debt securities or request a waiver.
Subordination Provisions
Holders of subordinated debt securities
should recognize that contractual provisions in the subordinated debt indenture may prohibit us from making payments on those securities.
Subordinated debt securities are subordinate and junior in right of payment, to the extent and in the manner stated in the subordinated
debt indenture, to all of our senior debt, as defined in the subordinated debt indenture, as it may be supplemented from time to
time, including all debt securities we have issued and will issue under the senior debt indenture.
The subordinated debt indenture defines
“senior debt” as the principal of (and premium, if any) and interest (including interest accruing on or after the filing
of any petition in bankruptcy or for reorganization relating to us) on all of our indebtedness (including indebtedness of others
guaranteed by us), other than the subordinated debt securities, whether outstanding on the date of the indenture or thereafter
created, incurred or assumed, which is (i) for money borrowed, (ii) evidenced by a note or similar instrument given in connection
with the acquisition of any businesses, properties or assets of any kind or (iii) obligations of ours as lessee under leases required
to be capitalized on the balance sheet of the lessee under generally accepted accounting principles or leases of property or assets
made as part of any sale and lease-back transaction to which we are a party, including amendments, renewals, extensions, modifications
and refundings of any such indebtedness or obligation, unless in any case in the instrument creating or evidencing any such indebtedness
or obligation or pursuant to which the same is outstanding it is provided that such indebtedness or obligation is not superior
in right of payment to the subordinated debt securities.
The subordinated debt indenture provides
that, unless all principal of and any premium or interest on the senior debt has been paid in full, no payment or other distribution
may be made in respect of any subordinated debt securities in the following circumstances:
|
·
|
in the event of any insolvency or bankruptcy proceedings, or any receivership, liquidation, reorganization
or other similar proceeding involving us or our assets;
|
|
·
|
(a) in the event and during the continuation of any default in the payment of principal, premium
or interest on any senior debt beyond any applicable grace period or if any event of default with respect to any senior debt of
ours has occurred and is continuing, permitting the holders of that senior debt of ours or a trustee to accelerate the maturity
of that senior debt, unless the event of default has been cured or waived or ceased to exist and any related acceleration has been
rescinded, or (b) if any judicial proceeding is pending with respect to a payment default or an event of default described in clause
(a); or
|
|
·
|
in the event that any subordinated debt securities have been declared due and payable before their
stated maturity.
|
If the trustee under the subordinated debt
indenture or any holders of the subordinated debt securities receive any payment or distribution that they know is prohibited under
the subordination provisions, then the trustee or the holders will have to repay that money to the holders of the senior debt.
Even if the subordination provisions prevent
us from making any payment when due on the subordinated debt securities of any series, we will be in default on our obligations
under that series if we do not make the payment when due. This means that the trustee under the subordinated debt indenture and
the holders of that series can take action against us, but they will not receive any money until the claims of the holders of senior
debt have been fully satisfied.
Events of Default
Unless the applicable prospectus supplement
provides otherwise, when we refer to an event of default with respect to any series of debt securities, we mean any of the following:
|
·
|
failure to pay interest on any debt security of that series within 30 days after its due date;
|
|
·
|
failure to pay the principal of or any premium on any debt security of that series on the due date;
|
|
·
|
failure to deposit a sinking fund payment with regard to any debt security of that series on the
due date, but only if the payment is required under the applicable prospectus supplement;
|
|
·
|
we remain in breach of any covenant we make in the indenture for the benefit of the relevant series
for 90 days after we receive a written notice of default stating that we are in breach and requiring us to remedy the breach. The
notice must be sent by the trustee or the holders of at least a majority in principal amount of the relevant series of debt securities;
or
|
|
·
|
the occurrence of specified bankruptcy, insolvency or reorganization events.
|
An event of default for one series of debt
securities does not necessarily constitute an event of default for any other series. The trustee may withhold notice to the debt
securities holders of any default, except a payment default, if it considers such action to be in the holders’ interests.
If the specified bankruptcy, insolvency
or reorganization events occur, the entire principal of all the debt securities of that series will be due and payable immediately.
If any other event of default occurs and continues, the trustee, or the holders of at least 25% in aggregate principal amount of
the outstanding debt securities of the series, may declare the entire principal of all the debt securities of that series to be
due and payable immediately. If this happens, and the issuer cures the event of default in the manner specified in the applicable
indenture, the holders of a majority of the aggregate outstanding principal amount of the debt securities of that series can void
the acceleration of payment.
The indentures provide that the trustee
has no obligation to exercise any of its rights at the direction of any holders, unless the holders offer the trustee reasonable
indemnity. If they provide this indemnification, the holders of a majority in principal amount of any series of debt securities
have the right to direct any proceeding, remedy, or power available to the trustee with respect to that series.
Book-entry and other indirect holders should
consult their banks, brokers or other financial institutions for information on how to give notice or direction to or make a request
of the trustee and to make or cancel a declaration of acceleration.
We will provide the trustee every year
with a written statement of certain of our officers certifying that to their knowledge we are in compliance with the applicable
indenture and the debt securities issued under it, or else specifying any default.
The Trustee
If we offer a series of debt securities,
we will identify the banking or financial institution which will act as trustee under the applicable indenture in the prospectus
supplement for that offering. If a single banking or financial institution acts as trustee with respect to both the indentures,
and a default occurs with respect to any series of debt securities, the banking or financial institution would generally be required
to resign as trustee under one of the indentures within 90 days of the default, unless the default were cured, duly waived or otherwise
eliminated.
Governing Law
Unless otherwise specified in an applicable
prospectus supplement, New York law will govern the indentures and the debt securities.
DESCRIPTION OF WARRANTS
We may issue warrants for the purchase
of shares of common stock, preferred stock or debt securities in one or more series. We may issue warrants independently or together
with shares of common stock, preferred stock and/or debt securities, and the warrants may be attached to or separate from these
securities.
We will describe the particular terms of
any series of warrants in more detail in the applicable prospectus supplement. Those terms may include:
|
·
|
the title of the warrants;
|
|
·
|
the aggregate number of the warrants;
|
|
·
|
the price or prices at which the warrants will be issued;
|
|
·
|
in the case of warrants to purchase common stock or preferred stock, the number of shares of common
stock or preferred stock, as the case may be, purchasable upon the exercise of one warrant and the price at which these shares
may be purchased upon such exercise;
|
|
·
|
the designation, aggregate principal amount, denominations and terms of the debt securities purchasable
upon exercise of a warrant to purchase debt securities and the price at which the debt securities may be purchased upon exercise;
|
|
·
|
if applicable, the date on and after which the warrants and the related securities will be separately
transferable;
|
|
·
|
the effect of any merger, consolidation, sale or other disposition of our business on the warrant
agreements and the warrants;
|
|
·
|
the terms of any rights to redeem or call the warrants;
|
|
·
|
any provisions for changes to or adjustments in the exercise price or number of securities issuable
upon exercise of the warrants;
|
|
·
|
the date on which the right to exercise the warrants will commence and the date on which the right
will expire;
|
|
·
|
if applicable, the minimum or maximum number of warrants that may be exercised at any one time;
|
|
·
|
the manner in which the warrant agreements and warrants may be modified;
|
|
·
|
information relating to book-entry procedures, if any;
|
|
·
|
if applicable, a discussion of material United States federal income tax considerations of holding
or exercising the warrants; and
|
|
·
|
any other terms of the warrants, including terms, procedures and limitations relating to the exchange
and exercise of the warrants.
|
Before exercising their warrants, holders
of warrants will not have any of the rights of holders of the securities purchasable upon such exercise, including:
|
·
|
in the case of warrants to purchase debt securities, the right to receive payments of principal
of, or premium, if any, or interest on, the debt securities purchasable upon exercise or to enforce covenants in the applicable
indenture; or
|
|
·
|
in the case of warrants to purchase common stock or preferred stock, the right to receive dividends,
if any, or, payments upon our liquidation, dissolution or winding up or to exercise voting rights, if any.
|
We will file as exhibits to the registration
statement of which this prospectus is a part, or will incorporate by reference from reports that we file with the SEC, the form
of warrant agreement, including a form of warrant certificate, that describes the terms of the particular series of warrants we
are offering before the issuance of the related series of warrants. The following summaries of material provisions of the warrants
and the warrant agreements are subject to, and qualified in their entirety by reference to, all the provisions of the warrant agreement
and warrant certificate applicable to the particular series of warrants that we may offer under this prospectus and the accompanying
prospectus supplement. We urge you to read the applicable prospectus supplements related to the particular series of warrants that
we may offer under this prospectus, as well as any related free writing prospectuses, and the complete warrant agreements and warrant
certificates that contain the terms of the warrants.
DESCRIPTION OF SUBSCRIPTION
RIGHTS
We may issue subscription rights to purchase
our securities. These subscription rights may be issued independently or together with any other security offered hereby and may
or may not be transferable by the stockholder receiving the subscription rights in such offering. In connection with any offering
of subscription rights, we may enter into a standby arrangement with one or more underwriters or other purchasers pursuant to which
the underwriters or other purchasers may be required to purchase any securities remaining unsubscribed for after such offering.
The applicable prospectus supplement will
describe the specific terms of any offering of subscription rights for which this prospectus is being delivered, including the
following:
|
·
|
whether common stock, preferred stock, or warrants for those securities will be offered under the
stockholder subscription rights;
|
|
·
|
the price, if any, for the subscription rights;
|
|
·
|
the exercise price payable for each security upon the exercise of the subscription rights;
|
|
·
|
the number of subscription rights issued to each stockholder;
|
|
·
|
the number and terms of the securities which may be purchased per each subscription right;
|
|
·
|
the extent to which the subscription rights are transferable;
|
|
·
|
any other terms of the subscription rights, including the terms, procedures and limitations relating
to the exchange and exercise of the subscription rights;
|
|
·
|
the date on which the right to exercise the subscription rights shall commence, and the date on
which the subscription rights shall expire;
|
|
·
|
the extent to which the subscription rights may include an over-subscription privilege with respect
to unsubscribed securities;
|
|
·
|
if appropriate, a discussion of material U.S. federal income tax considerations; and
|
|
·
|
if applicable, the material terms of any standby underwriting or purchase arrangement entered into
by us in connection with the offering of subscription rights.
|
The preceding summary of the terms of the
subscription rights does not purport to be complete and is subject to, and is qualified in its entirety by reference to, the terms
of the subscription rights being offered, as well as any applicable subscription rights certificate and the terms of the securities
to which the subscription rights relate. Therefore, you should carefully consider the actual provisions of the subscription right,
and subscription agreement and the applicable securities.
DESCRIPTION OF UNITS
We may issue units comprised of one or
more of the other securities described in this prospectus or any prospectus supplement in any combination. The specific terms of
any series of units will be described in the applicable prospectus supplement or free writing prospectus. If so described in a
particular prospectus supplement or free writing prospectus, the specific terms of any series of units may differ from the general
description of terms presented below.
Each unit will be issued so that the holder
of the unit is also the holder, with the rights and obligations of a holder, of each security included in the unit. The units may
be issued under unit agreements to be entered into between us and a unit agent, which may provide that the securities included
in the unit may not be held or transferred separately, at any time or times before a specified date or upon the occurrence of a
specified event or occurrence.
The applicable prospectus supplement will
specify the following terms of any units in respect of which this prospectus is being delivered:
|
·
|
the designation of the terms of the units and of any of the shares of common stock, shares of preferred
stock, debt securities, warrants, or subscription rights comprising the units, including whether and under what circumstances the
securities comprising the units may be traded separately;
|
|
·
|
a description of the terms of any unit agreement governing the units;
|
|
·
|
if appropriate, a discussion of material U.S. federal income tax considerations;
|
|
·
|
a description of the provisions for the payment, settlement, transfer or exchange of the units;
and
|
|
·
|
whether the units, if issued as a separate security, bill be issued in fully registered or global
form.
|
The preceding summary of the terms of the
units does not purport to be complete and is subject to, and is qualified in its entirety by reference to, the terms of the units
being offered, as well as any applicable unit agreement and the terms of the applicable classes of securities comprising the unit.
Therefore, you should carefully consider the actual provisions of the unit, any unit agreement and the applicable securities.
LEGAL OWNERSHIP OF
SECURITIES
We can issue securities in registered form
or in the form of one or more global securities. We describe global securities in greater detail below. We refer to those persons
who have securities registered in their own names on the books that we or any applicable trustee, depositary or warrant agent maintain
for this purpose as the “holders” of those securities. These persons are the legal holders of the securities. We refer
to those persons who, indirectly through others, own beneficial interests in securities that are not registered in their own names
as “indirect holders” of those securities. As we discuss below, indirect holders are not legal holders and investors
in securities issued in book-entry form or in street name will be indirect holders.
Legal Holders
Our obligations, as well as the obligations
of any applicable trustee and of any third parties employed by us or a trustee, run only to the legal holders of the securities.
We do not have obligations to investors who hold beneficial interests in global securities, in street name or by any other indirect
means. This will be the case whether an investor chooses to be an indirect holder of a security or has no choice because we are
issuing the securities only in global form.
For example, once we make a payment or
give a notice to the holder, we have no further responsibility for the payment or notice even if that holder is required, under
agreements with depositary participants or customers or by law, to pass it along to the indirect holders but does not do so. Similarly,
we may want to obtain the approval of the holders to amend an indenture, to relieve us of the consequences of a default or of our
obligation to comply with a particular provision of the indenture or for other purposes. In such an event, we would seek approval
only from the holders, and not the indirect holders, of the securities. Whether and how the holders contact the indirect holders
is up to the holders.
Special Considerations For Indirect Holders
If you hold securities through a bank,
broker or other financial institution, either in book-entry form or in street name, you should check with your own institution
to find out:
|
·
|
how it handles securities payment and notices;
|
|
·
|
whether it imposes fees or charges;
|
|
·
|
how it would handle a request for the holders’ consents, if ever required;
|
|
·
|
whether and how you can instruct it to send your securities registered in your own name so you
can be a registered holder;
|
|
·
|
how it would exercise rights under the securities if there were a default or other event triggering
the need for holders to act to protect their interests; and
|
|
·
|
if the securities are in book-entry form, how the depositary’s rules and procedures will
affect these matters.
|
Book-Entry Holders
We may issue securities in book-entry form
only, as we will specify in the applicable prospectus supplement. This means securities may be represented by one or more global
securities registered in the name of a financial institution that holds them as depositary on behalf of other financial institutions
that participate in the depositary’s book-entry system. These participating institutions, which are referred to as participants,
in turn, hold beneficial interests in the securities on behalf of themselves or their customers.
Only the person in whose name a security
is registered is recognized as the holder of that security. Securities issued in global form will be registered in the name of
the depositary or its participants. Consequently, for securities issued in global form, we will recognize only the depositary as
the holder of the securities, and we will make all payments on the securities to the depositary. The depositary passes along the
payments it receives to its participants, which in turn pass the payments along to their customers who are the beneficial owners.
The depositary and its participants do so under agreements they have made with one another or with their customers; they are not
obligated to do so under the terms of the securities.
As a result, investors in a book-entry
security will not own securities directly. Instead, they will own beneficial interests in a global security, through a bank, broker
or other financial institution that participates in the depositary’s book-entry system or holds an interest through a participant.
As long as the securities are issued in global form, investors will be indirect holders, and not holders, of the securities.
Street Name Holders
We may terminate a global security or issue
securities in non-global form. In these cases, investors may choose to hold their securities in their own names or in “street
name.” Securities held by an investor in street name would be registered in the name of a bank, broker or other financial
institution that the investor chooses, and the investor would hold only a beneficial interest in those securities through an account
he or she maintains at that institution.
For securities held in street name, we
will recognize only the intermediary banks, brokers and other financial institutions in whose names the securities are registered
as the holders of those securities, and we will make all payments on those securities to them. These institutions pass along the
payments they receive to their customers who are the beneficial owners, but only because they agree to do so in their customer
agreements or because they are legally required to do so. Investors who hold securities in street name will be indirect holders,
not holders, of those securities.
Global Securities
A global security is a security that represents
one or any other number of individual securities held by a depositary. Generally, all securities represented by the same global
securities will have the same terms.
Each security issued in book-entry form
will be represented by a global security that we deposit with and register in the name of a financial institution or its nominee
that we select. The financial institution that we select for this purpose is called the depositary. Unless we specify otherwise
in the applicable prospectus supplement, The Depository Trust Company, New York, New York, known as DTC, will be the depositary
for all securities issued in book-entry form.
A global security may not be transferred
to or registered in the name of anyone other than the depositary, its nominee or a successor depositary, unless special termination
situations arise. We describe those situations below under “Special Situations When a Global Security Will Be Terminated.”
As a result of these arrangements, the depositary, or its nominee, will be the sole registered owner and holder of all securities
represented by a global security, and investors will be permitted to own only beneficial interests in a global security. Beneficial
interests must be held by means of an account with a broker, bank or other financial institution that in turn has an account with
the depositary or with another institution that does. Thus, an investor whose security is represented by a global security will
not be a holder of the security, but only an indirect holder of a beneficial interest in the global security.
If the prospectus supplement for a particular
security indicates that the security will be issued in global form only, then the security will be represented by a global security
at all times unless and until the global security is terminated. If termination occurs, we may issue the securities through another
book-entry clearing system or decide that the securities may no longer be held through any book-entry clearing system.
Special Considerations For Global Securities
As an indirect holder, an investor’s
rights relating to a global security will be governed by the account rules of the investor’s financial institution and of
the depositary, as well as general laws relating to securities transfers. We do not recognize an indirect holder as a holder of
securities and instead deal only with the depositary that holds the global security.
If securities are issued only in the form
of a global security, an investor should be aware of the following:
|
·
|
an investor cannot cause the securities to be registered in his or her name, and cannot obtain
non-global certificates for his or her interest in the securities, except in the special situations we describe below;
|
|
·
|
an investor will be an indirect holder and must look to his or her own bank or broker for payments
on the securities and protection of his or her legal rights relating to the securities, as we describe above;
|
|
·
|
an investor may not be able to sell interests in the securities to some insurance companies and
to other institutions that are required by law to own their securities in non-book-entry form;
|
|
·
|
an investor may not be able to pledge his or her interest in a global security in circumstances
where certificates representing the securities must be delivered to the lender or other beneficiary of the pledge in order for
the pledge to be effective;
|
|
·
|
the depositary’s policies, which may change from time to time, will govern payments, transfers,
exchanges and other matters relating to an investor’s interest in a global security. We and any applicable trustee have no
responsibility for any aspect of the depositary’s actions or for its records of ownership interests in a global security.
We and the trustee also do not supervise the depositary in any way;
|
|
·
|
the depositary may, and we understand that DTC will, require that those who purchase and sell interests
in a global security within its book-entry system use immediately available funds, and your broker or bank may require you to do
so as well; and
|
|
·
|
financial institutions that participate in the depositary’s book-entry system, and through
which an investor holds its interest in a global security, may also have their own policies affecting payments, notices and other
matters relating to the securities
|
There may be more than one financial intermediary
in the chain of ownership for an investor. We do not monitor and are not responsible for the actions of any of those intermediaries.
Special Situations When A Global Security Will Be Terminated
In a few special situations described below,
the global security will terminate and interests in it will be exchanged for physical certificates representing those interests.
After that exchange, the choice of whether to hold securities directly or in street name will be up to the investor. Investors
must consult their own banks or brokers to find out how to have their interests in securities transferred to their own name, so
that they will be direct holders. We have described the rights of holders and street name investors above.
A global security will terminate when the
following special situations occur:
|
·
|
if the depositary notifies us that it is unwilling, unable or no longer qualified to continue as
depositary for that global security and we do not appoint another institution to act as depositary within 90 days;
|
|
·
|
if we notify any applicable trustee that we wish to terminate that global security; or
|
|
·
|
if an event of default has occurred with regard to securities represented by that global security
and has not been cured or waived.
|
The applicable prospectus supplement may
also list additional situations for terminating a global security that would apply only to the particular series of securities
covered by the prospectus supplement. When a global security terminates, the depositary, and not we or any applicable trustee,
is responsible for deciding the names of the institutions that will be the initial direct holders.
SELLING STOCKHOLDERS
This prospectus also relates to the possible
resale or other disposition by certain stockholders who acquired their shares directly from the Company as consideration for the
sale of their company or pursuant to the exercise of options, or as a grant of stock under the Company’s equity incentive
plan.
PLAN OF DISTRIBUTION
We, or the selling stockholders, may sell
the securities offered under this prospectus from time to time in any one or more of the following ways:
|
·
|
to or through underwriters, brokers or dealers (acting as agent or principal);
|
|
·
|
directly to one or more other purchasers;
|
|
·
|
upon the exercise of rights distributed or issued to our security holders;
|
|
·
|
through a block trade in which the broker or dealer engaged to handle the block trade will attempt
to sell the securities as agent, but may position and resell a portion of the block as principal to facilitate the transaction;
|
|
·
|
in “at the market” offerings within the meanings of Rule 415(a)(4) under the Securities
Act of 1933 or through a market maker or into an existing market, on an exchange, or otherwise;
|
|
·
|
directly to purchasers, through a specific bidding or auction process, on a negotiated basis or
otherwise;
|
|
·
|
through agents on a best-efforts basis;
|
|
·
|
through any other method permitted pursuant to applicable law; or
|
|
·
|
otherwise through a combination of any of the above methods of sale.
|
Sales of securities may be effected from
time to time in one or more transactions, including negotiated transactions:
|
·
|
at a fixed price or prices, which may be changed;
|
|
·
|
at market prices prevailing at the time of sale;
|
|
·
|
at prices related to prevailing market prices; or
|
Any selling stockholder will act independently
of us in making decisions with respect to the timing, manner and size of each sale of shares of common stock covered by this prospectus.
Each time that we, or the selling stockholders,
sell securities pursuant to this prospectus, we will provide a prospectus supplement or supplements that will describe the method
of distribution and set forth the terms and conditions of the offering of such securities, including the following information:
|
·
|
the terms of the offering;
|
|
·
|
the names of any underwriters, dealers or agents;
|
|
·
|
the name or names of any managing underwriter or underwriters;
|
|
·
|
the purchase price of the securities;
|
|
·
|
the net proceeds from the sale of the securities;
|
|
·
|
any underwriting discounts, concessions, commissions or agency fees and other items constituting
underwriters', dealers' or agents' compensation;
|
|
·
|
any delayed delivery arrangements; and
|
|
·
|
estimated offering expenses.
|
We may engage in at-the-market offerings
into an existing trading market in accordance with Rule 415(a)(4) under the Securities Act. Any at-the market offering will be
through an underwriter or underwriters acting as principal or agent for us.
We may issue to our existing security holders,
through a dividend or similar distribution, subscription rights to purchase shares of our common stock or preferred stock, which
may or may not be transferable. In any distribution of subscription rights to our existing security holders, if all of the underlying
securities are not subscribed for, we may then sell the unsubscribed securities directly to third parties or may engage the services
of one or more underwriters, dealers or agents, including standby underwriters, to sell the unsubscribed securities to third parties.
The applicable prospectus supplement will describe the specific terms of any offering of our common stock or preferred stock through
the issuance of subscription rights, including, if applicable, the material terms of any standby underwriting or purchase arrangement.
The anticipated date of delivery of the securities offered by this prospectus will be described in the applicable prospectus supplement
relating to the offering.
Sale Through Underwriters or Dealers.
The securities may be offered to the public
either through underwriting syndicates represented by one or more managing underwriters or directly by one or more of such firms.
Unless otherwise set forth in the prospectus supplement, the obligations of underwriters or dealers to purchase the securities
offered will be subject to certain conditions precedent and the underwriters or dealers will be obligated to purchase all the offered
securities if any are purchased. Any public offering price and any discount or concession allowed or reallowed or paid by underwriters
or dealers to other dealers may be changed from time to time.
Selling stockholders and broker-dealers
or agents involved in an arrangement to sell any of the offered securities may, under certain circumstances, be deemed to be “underwriters”
within the meaning of the Securities Act. Any profit on such sales and any discount, commission, concession or other compensation
received by any such underwriter, broker-dealer or agent may be deemed an underwriting discount and commission under the Exchange
Act. No selling stockholder has informed us that they have an agreement or understanding, directly or indirectly, with any person
to distribute the common stock covered by this prospectus. If a selling stockholder should notify us that they have a material
arrangement with a broker-dealer for the resale of their shares, we may be required to amend the registration statement of which
this prospectus is a part, and file a prospectus supplement to describe the agreement between the selling stockholder and broker-dealer
or agent, provide required information regarding the plan of distribution, and otherwise revise the disclosure in this prospectus
as needed. We also may be required to file the agreement between the selling stockholder and the broker-dealer as an exhibit to
the registration statement. Except as indicated in the applicable prospectus supplement, the selling stockholder and/or purchasers
will pay all discounts, concessions, commissions and similar selling expenses, if any, that can be attributed to the sale of the
shares of such common stock.
We, or the selling stockholders, may grant
to the underwriters options to purchase additional securities at the public offering price, with additional underwriting commissions
or discounts, as applicable, set forth in the prospectus supplement. The terms of any option to purchase additional securities
will be set forth in the prospectus supplement for those securities.
Direct Sales and Sales through Agents
We, or the selling stockholders, may sell
the securities offered through this prospectus directly. In this case, no underwriters, dealers or agents would be involved. Such
securities may also be sold through agents designated from time to time. The prospectus supplement will name any agent involved
in the offer or sale of the offered securities and will describe any commissions payable to the agent. Unless otherwise indicated
in the prospectus supplement, any agent will agree to use its reasonable best efforts to solicit purchases for the period of its
appointment.
We, or the selling stockholders, may sell
the securities directly to institutional investors or others who may be deemed to be underwriters within the meaning of the Securities
Act with respect to any sale of those securities. The terms of any such sales will be described in the prospectus supplement relating
to the offer.
Delayed Delivery Contracts
If indicated in the applicable prospectus
supplement, we may authorize underwriters, dealers or agents to solicit offers by certain institutional investors to purchase securities
at the public offering price under delayed delivery contracts. These contracts would provide for payment and delivery on a specified
date in the future. The contracts would be subject only to those conditions described in the prospectus supplement. The applicable
prospectus supplement will describe the commission payable for solicitation of those contracts.
Market Making, Stabilization and Other Transactions
All securities we may offer pursuant to
this prospectus, other than common stock, will be new issues of securities with no established trading market. Any underwriters
may make a market in these securities, but will not be obligated to do so and may discontinue any market making at any time without
notice. We cannot guarantee the liquidity of the trading markets for any securities.
Any underwriter may engage in over-allotment,
stabilizing transactions, short-covering transactions and penalty bids in accordance with Regulation M under the Exchange Act.
Over-allotment involves sales in excess of the offering size, which create a short position. Stabilizing transactions permit bids
to purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum price. Syndicate-covering
or other short-covering transactions involve purchases of the securities, either through exercise of the over-allotment option
or in the open market after the distribution is completed, to cover short positions. Penalty bids permit the underwriters to reclaim
a selling concession from a dealer when the securities originally sold by the dealer are purchased in a stabilizing or covering
transaction to cover short positions. Those activities may cause the price of the securities to be higher than it would otherwise
be. If commenced, the underwriters may discontinue any of the activities at any time.
Any underwriters or agents that are qualified
market makers may engage in passive market making transactions in the common stock in accordance with Regulation M under the Exchange
Act, during the business day prior to the pricing of the offering, before the commencement of offers or sales of our common stock.
Passive market makers must comply with applicable volume and price limitations and must be identified as passive market makers.
In general, a passive market maker must display its bid at a price not in excess of the highest independent bid for such security;
if all independent bids are lowered below the passive market maker’s bid, however, the passive market maker’s bid must
then be lowered when certain purchase limits are exceeded. Passive market making may stabilize the market price of the securities
at a level above that which might otherwise prevail in the open market and, if commenced, may be discontinued at any time.
Derivative Transactions and Hedging
We, or the selling stockholders, may enter
into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties in privately
negotiated transactions. If the applicable prospectus supplement indicates, in connection with those derivatives, the third parties
may sell securities covered by this prospectus and the applicable prospectus supplement, including in short sale transactions.
If so, the third party may use securities pledged by us or the selling stockholders, or borrowed from us, the selling stockholders,
or others to settle those sales or to close out any related open borrowings of stock, and may use securities received from us or
the selling stockholders in settlement of those derivatives to close out any related open borrowings of stock. The third party
in such sale transactions will be an underwriter and, if not identified in this prospectus, will be identified in the applicable
prospectus supplement (or a post-effective amendment). In addition, we, or the selling stockholders, may otherwise loan or pledge
securities to a financial institution or other third party that in turn may sell the securities short using this prospectus. Such
financial institution or other third party may transfer its economic short position to investors in our securities, or the securities
of such selling stockholders, as applicable, or in connection with a concurrent offering of other securities.
We, or the selling stockholders, may enter
into option, share lending or other types of transactions that require us or the selling stockholders, as applicable, to deliver
shares of common stock to an underwriter, broker or dealer, who will then resell or transfer the shares of common stock under this
prospectus. We, or the selling stockholders, may also enter into hedging transactions with respect to our securities. For example,
we may enter into option or other types of transactions that require us to deliver shares of common stock to an underwriter, broker
or dealer, who will then resell or transfer the shares of common stock under this prospectus; or loan or pledge the shares of common
stock to an underwriter, broker or dealer, who may sell the loaned shares or, in the event of default, sell the pledged shares.
Electronic Auctions
We may also make sales through the Internet
or through other electronic means. Since we may from time to time elect to offer securities directly to the public, with or without
the involvement of agents, underwriters or dealers, utilizing the Internet or other forms of electronic bidding or ordering systems
for the pricing and allocation of such securities, you will want to pay particular attention to the description of that system,
which we will provide in a prospectus supplement.
Such electronic system may allow bidders
to directly participate, through electronic access to an auction site, by submitting conditional offers to buy that are subject
to acceptance by us, and which may directly affect the price or other terms and conditions at which such securities are sold.
These bidding or ordering systems may present to each bidder, on a so-called "real-time" basis, relevant information
to assist in making a bid, such as the clearing spread at which the offering would be sold, based on the bids submitted, and whether
a bidder's individual bids would be accepted, prorated or rejected. For example, in the case of debt security, the clearing spread
could be indicated as a number of "basis points" above an index treasury note.
Upon completion of such an electronic auction
process, securities will be allocated based on prices bid, terms of bid or other factors. The final offering price at which securities
would be sold and the allocation of securities among bidders would be based in whole or in part on the results of the Internet
or other electronic bidding process or auction.
General Information
Any securities initially sold outside the
U.S. may be resold in the U.S. through underwriters, dealers or otherwise.
Any shares of common stock covered by this
prospectus that qualify for sale pursuant to Rule 144 under the Securities Act of 1933 may be sold under Rule 144 rather than pursuant
to this prospectus.
To comply with the securities laws of some
states, if applicable, the securities that may be offered pursuant to this prospectus may be sold in these jurisdictions only through
registered or licensed brokers or dealers. In addition, in some states the securities may not be sold unless they have been registered
or qualified for sale or an exemption from registration or qualification requirements is available and is complied with.
In compliance with the guidelines of the
Financial Industry Regulatory Authority, or FINRA, the aggregate maximum discount, commission, agency fees or other items constituting
underwriting compensation to be received by any FINRA member or independent broker-dealer will not exceed such amounts as is determined
to be unfair or unreasonable under applicable FINRA rules.
Some of the underwriters, dealers or agents
used by us in any offering of securities under this prospectus may be customers of, engage in transactions with, and perform services
for us or affiliates of ours in the ordinary course of business. Underwriters, dealers, agents and other persons may be entitled
under agreements which may be entered into with us to indemnification against and contribution toward certain civil liabilities,
including liabilities under the Securities Act, and to be reimbursed by us for certain expenses.
No FINRA member may participate in any
offering of securities made under this prospectus if such member has a conflict of interest under FINRA Rule 5121 unless a qualified
independent underwriter has participated in the offering or the offering otherwise complies with FINRA Rule 5121.
LEGAL MATTERS
Certain legal matters with respect to the
primary offering contemplated hereby have been passed upon for us by Sheppard, Mullin, Richter & Hampton LLP, Los Angeles,
California. Additional legal matters may be passed upon for us or any underwriters, dealers or agents, by counsel that we will
name in the applicable prospectus supplement.
EXPERTS
The consolidated financial statements of RadNet, Inc. and subsidiaries
appearing in RadNet, Inc.’s Annual Report (Form 10-K) for the year ended December 31, 2018 (including the schedule appearing
therein), and the effectiveness of RadNet, Inc.’s internal control over financial reporting as of December 31, 2018 have
been audited by Ernst & Young LLP, independent registered public accounting firm, as set forth in their reports thereon, included
therein, and incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference in
reliance upon such reports given on the authority of such firm as experts in accounting and auditing.
PART II
INFORMATION NOT REQUIRED
IN PROSPECTUS
Item 14. Other Expenses of Issuance and Distribution.
The following table
sets forth the estimated fees and expenses, other than underwriting discounts and commissions, expected to be incurred in connection
with the offering or offerings described in this registration statement.
Item
|
|
Amount
|
|
Securities and Exchange Commission registration fee
|
|
$
|
*
|
|
FINRA filing fee
|
|
|
*
|
|
Trustee fees and expenses
|
|
|
**
|
|
Rating agency fees
|
|
|
**
|
|
Legal fees and expenses
|
|
|
**
|
|
Accounting fees and expenses
|
|
|
**
|
|
Transfer agent and registrar fees and expenses
|
|
|
**
|
|
Printing and EDGAR filing fees and expenses
|
|
|
**
|
|
Miscellaneous
|
|
|
**
|
|
Total
|
|
$
|
**
|
|
_______________________
* In accordance with
Rules 456(b) and 457(r) under
the Securities Act, the registrant
is deferring payment of the registration fee associated with this registration statement.
** These
fees are variable based on the securities offered and the number of issuances and accordingly cannot be estimated at this time.
The applicable prospectus supplement will set forth the estimated amount of expenses incurred in connection with securities to
be offered and sold pursuant to this registration statement.
We have agreed to pay all costs, expenses
and fees relating to registering the shares of our common stock to be sold by the selling stockholders and referenced in this prospectus.
The selling stockholders will pay any brokerage commissions and/or similar charges incurred for the sale of such shares of our
common stock.
Item 15. Indemnification of Directors and Officers.
Delaware General Corporation Law
Section 145 of the DGCL permits a corporation
to indemnify any director, officer, employee or agent of the corporation, or other person who is or was serving at the request
of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other
enterprise, any such person referred to as an indemnitee, against expenses (including attorney’s fees), judgments, fines
and amounts paid in settlement actually and reasonably incurred in connection with any action, suit or proceeding brought by reason
of the fact that the indemnitee is or was serving the corporation or another entity at the direction of the corporation, provided
that the indemnitee acted in good faith and in a manner that he or she reasonably believed to be in, or not opposed to, the best
interests of the corporation, and, with respect to any criminal action or proceeding, if he or she had no reason to believe his
or her conduct was unlawful. In a derivative action (i.e., one brought by or on behalf of the corporation), indemnification may
be provided only for expenses actually and reasonably incurred by the indemnitee in connection with the defense or settlement of
such an action or suit if the indemnitee acted in good faith and in a manner that he or she reasonably believed to be in, or not
opposed to, the best interests of the corporation, except that no indemnification shall be provided if the indemnitee is adjudged
to be liable to the corporation, unless and only to the extent that the court in which the action or suit was brought determines
that the indemnitee is fairly and reasonably entitled to indemnity for his or her expenses despite the adjudication of liability.
Section 145(g) of the DGCL also provides
that a corporation may maintain insurance against liabilities even if the corporation would lack the power under the DGCL to indemnify
against those liabilities.
Certificate of Incorporation and Bylaws
Article Ninth of the registrant’s
certificate of incorporation provides that a director is not liable to the registrant or its stockholders for monetary damages
for breach of fiduciary duty as a director to the fullest extent permitted by the DGCL. It further obligates the registrant, with
respect to its officers and directors, and permits the registrant, with respect to its employee and agents, to indemnify, in the
manner and to the fullest extent permitted by the DGCL, any person (or the estate of any person) who is or was a party to, or is
threatened to be made a party to, any threatened, pending or completed action, suit or proceeding, whether or not by or in the
right of the registrant, and whether civil, criminal, administrative, investigative or otherwise, by reason of the fact that the
person is or was a director or officer, or employee or agent, as the case may be, of the registrant, or is or was serving at the
request of the registrant as a director or officer, or employee or agent, as the case may be, of another corporation or entity.
The registrant may advance the expenses incurred by any such director, officer, employee or agent in defending any such action,
suit or proceeding prior to its final disposition upon receipt of an undertaking by the recipient to repay the amounts advanced
if it is ultimately determined that he or she is not entitled to be indemnified as authorized by the DGCL and the registrant’s
certificate of incorporation. To the fullest extent permitted by the DGCL, the indemnification provided in the certificate of incorporation
includes expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement and, in the manner provided
by the DGCL, the registrant may pay any of these expenses in advance of the final disposition of such action, suit or proceeding.
Except as described in this paragraph,
Article VII of the registrant’s bylaws contains provisions substantially similar to Article Ninth of the registrant’s
certificate of incorporation. In addition, the registrant’s bylaws obligate the registrant to indemnify each of its officers,
directors, employees and agents in any action, suit or proceeding referred to above to the extent that person has been successful
on the merits in defense thereof, or in defense of any claim, issue or matter therein, against expenses (including attorneys’
fees) actually and reasonably incurred by that person in connection therewith. The registrant’s bylaws obligate the registrant
to advance expenses to its officers and directors, and require an undertaking to repay expenses under the specified conditions
if required by applicable law.
General
The registrant also maintains insurance
for its officers and directors against certain liabilities, including liabilities under the Securities Act. The effect of this
insurance is to indemnify any officer or director of the registrant against expenses, including attorneys’ fees, judgments,
fines and amounts paid in settlement, incurred by an officer or director upon a determination that such person acted in good faith.
The registrant pays the premiums for this insurance.
The registrant has also entered into separate
indemnification agreements with its officers and directors, which indemnify the officer or director against all liabilities relating
to his or her position as an officer or director of the registrant, or as an employee, agent, officer or director of any other
entity if the officer or director is serving in that capacity at the registrant’s request, to the fullest extent permitted
under applicable law.
Insofar as indemnification for liabilities
arising under the Securities Act may be permitted to the registrant’s directors, officers or controlling persons pursuant
to the foregoing provisions, the registrant has been informed that, in the opinion of the SEC, such indemnification is against
public policy as expressed in the Securities Act and is, therefore, unenforceable. In addition, indemnification for violations
of state securities laws may be limited by applicable laws.
Item 16. Exhibits.
The following documents are filed as exhibits
to this registration statement:
Exhibit No.
|
|
Description
|
|
Filed Herewith
|
|
Incorporated by Reference to
|
|
1.1
|
|
Form of Underwriting Agreement (Equity)
|
|
|
|
*
|
|
1.2
|
|
Form of Underwriting Agreement (Debt) Securities)
|
|
|
|
*
|
|
3.1
|
|
Certificate of Incorporation dated June 19, 2008
|
|
|
|
Exhibit 3.1 to Current Report on Form 8-K Filed on September 4, 2008
|
|
3.2
|
|
Certificate of Amendment
|
|
|
|
Exhibit 3.2 to Current Report on Form 8-K Filed on September 4, 2008
|
|
3.3
|
|
Bylaws
|
|
|
|
Exhibit 3.3 to Current Report on Form 8-K Filed on September 4, 2008
|
|
4.1
|
|
Form of Common Stock Certificate
|
|
|
|
Exhibit 4.1 to Annual Report on Form 10-K filed on February 7, 2007
|
|
4.2
|
|
Form of Senior Debt Indenture
|
|
|
|
Exhibit 4.2 to Form S-3 filed on December 30, 2014
|
|
4.3
|
|
Form of Senior Debt Security (included in Exhibit 4.2)
|
|
|
|
|
|
4.4
|
|
Form of Subordinated Debt Indenture
|
|
|
|
Exhibit 4.4 to Form S-3 filed on December 30, 2014
|
|
4.5
|
|
Form of Subordinated Debt Security (included in Exhibit 4.4)
|
|
|
|
|
|
4.6
|
|
Form of Capital Stock Warrant Agreement
|
|
|
|
*
|
|
4.7
|
|
Form of Capital Stock Warrant Certificate
|
|
|
|
*
|
|
4.8
|
|
Form of Debt Securities Warrant Agreement
|
|
|
|
*
|
|
4.9
|
|
Form of Debt Securities Warrant Certificate
|
|
|
|
*
|
|
4.10
|
|
Form of Subscription Right
|
|
|
|
*
|
|
4.11
|
|
Form of Unit Agreement
|
|
|
|
*
|
|
4.12
|
|
Form of Unit Certificate
|
|
|
|
*
|
|
5.1
|
|
Legal Opinion of Sheppard, Mullin, Richter & Hampton LLP
|
|
×
|
|
|
|
23.1
|
|
Consent of Ernst & Young LLP
|
|
×
|
|
|
|
23.2
|
|
Consent of Sheppard, Mullin, Richter & Hampton LLP (included in Exhibit 5.1)
|
|
×
|
|
|
|
24.1
|
|
Power of Attorney (included on signature page)
|
|
×
|
|
|
|
25.1
|
|
Form T-1 Statement of Eligibility of Trustee Qualification on Form T-under the Senior Indenture
|
|
|
|
**
|
|
25.2
|
|
Form T-1 Statement of Eligibility of Trustee Qualification on Form T-under the Subordinated Indenture
|
|
|
|
**
|
___________________________
|
*
|
To be filed by amendment hereto or as an exhibit to a report
filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 and incorporated herein by reference, if applicable.
|
|
**
|
To be filed with the SEC on Form T-1 within two business
days following the offering or sale of the debt securities represented thereby, pursuant to Rule 5b-3 promulgated under the Trust
Indenture Act of 1939, if applicable.
|
Item 17. Undertakings.
The undersigned registrant hereby undertakes:
1. To file,
during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
|
i.
|
To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;
|
|
ii.
|
To reflect in the prospectus any facts or events arising after the effective date of the registration
statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental
change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume
of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation
from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC
pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum
aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement.
|
|
iii.
|
To include any material information with respect to the plan of distribution not previously disclosed
in the registration statement or any material change to such information in the registration statement;
|
provided, however,
that paragraphs (l)(i), (l)(ii) and (l)(iii) do not apply if the information required to be included in a post-effective amendment
by those paragraphs is contained in reports filed with or furnished to the U.S. Securities and Exchange Commission by the registrant
pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference into this registration
statement, or that are contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.
2. That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment
shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.
3. To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold
at the termination of the offering.
4. That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:
|
i.
|
Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of
the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and
|
|
ii.
|
Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a
registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the
purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and
included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness
or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B,
for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new
effective date of the registration statement relating to the securities in the registration statement to which that prospectus
relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement
or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part
of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or
modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made
in any such document immediately prior to such effective date.
|
5. That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the
initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned
registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser,
if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant
will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:
|
i.
|
Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering
required to be filed pursuant to Rule 424;
|
|
ii.
|
Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned
registrant or used or referred to by the undersigned registrant;
|
|
iii.
|
The portion of any other free writing prospectus relating to the offering containing material information
about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and
|
|
iv.
|
Any other communication that is an offer in the offering made by the undersigned registrant to
the purchaser.
|
6. That, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant’s
annual report pursuant to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing
of an employee benefit plan’s annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated
by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
7. The undersigned registrant hereby undertakes to supplement the prospectus, after the expiration of the subscription period,
to set forth the results of the subscription offer, the transactions by the underwriters during the subscription period, the amount
of unsubscribed securities to be purchased by the underwriters, and the terms of any subsequent reoffering thereof. If any public
offering by the underwriters is to be made on terms differing from those set forth on the cover page of the prospectus, a post-effective
amendment will be filed to set forth the terms of such offering.
8. Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers
and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that
in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act
and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment
by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful
defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities
being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed
in the Act and will be governed by the final adjudication of such issue.
9. To file an application for the purpose of determining the eligibility of the Trustee to act under subsection (a) of Section
310 of the Trust Indenture Act in accordance with the rules and regulations prescribed by the Securities and Exchange Commission
under Section 305(b)(2) of the Trust Indenture Act.
SIGNATURES
Pursuant to the requirements
of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of Los Angeles, State of California, on December 26, 2019.
|
RADNET, INC., a Delaware corporation
|
|
|
|
By: /s/ Howard G. Berger, M.D.
|
|
Howard G. Berger, M.D.
|
|
President, Chief Executive
Officer and Director (Principal Executive Officer)
|
POWER OF ATTORNEY
Each person whose signature
appears below hereby constitutes and appoints Howard G. Berger, M.D. and Mark D. Stolper, and each of them acting individually,
as his or her true and lawful attorneys-in-fact and agents, each with full power of substitution, for him or her in any and all
capacities, to sign any and all amendments to this registration statement, including post-effective amendments or any abbreviated
registration statement and any amendments thereto filed pursuant to Rule 462(b) increasing the number of securities for which registration
is sought, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and
Exchange Commission, granting unto said attorneys-in-fact and agents, with full power of each to act alone, full power and authority
to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents
and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents,
or his or her or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements
of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in their capacities
and on the date indicated.
Signature
|
|
Title
|
|
Date
|
/s/ Howard G. Berger, M.D.
|
|
Director, Chief Executive Officer and
|
|
December 26, 2019
|
Howard G. Berger, M.D.
|
|
President (Principal Executive Officer)
|
|
|
|
|
|
|
|
/s/ Marvin S. Cadwell
|
|
Director
|
|
December 26, 2019
|
Marvin S. Cadwell
|
|
|
|
|
|
|
|
|
|
/s/ John V. Crues, III, M.D.
|
|
Director
|
|
December 26, 2019
|
John V. Crues, III, M.D.
|
|
|
|
|
|
|
|
|
|
/s/ Lawrence L. Levitt
|
|
Director
|
|
December 26, 2019
|
Lawrence L. Levitt
|
|
|
|
|
|
|
|
|
|
/s/ Michael L. Sherman, M.D.
|
|
Director
|
|
December 26, 2019
|
Michael L. Sherman, M.D.
|
|
|
|
|
|
|
|
|
|
/s/ Mark D. Stolper
|
|
Chief Financial Officer (Principal Financial
|
|
December 26, 2019
|
Mark D. Stolper
|
|
Officer and Principal Accounting Officer)
|
|
|
|
|
|
|
|
/s/ David L. Swartz
|
|
Director
|
|
December 26, 2019
|
David L. Swartz
|
|
|
|
|
|
|
|
|
|
/s/ Ruth Wilson
|
|
Director
|
|
December 26, 2019
|
Ruth Wilson
|
|
|
|
|
|
|
|
|
|
RadNet (NASDAQ:RDNT)
Historical Stock Chart
From Aug 2024 to Sep 2024
RadNet (NASDAQ:RDNT)
Historical Stock Chart
From Sep 2023 to Sep 2024